Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organization

Glioblastoma (GBM) is an extremely aggressive and incurable primary brain tumor with a 10-year survival of just 0.71%. Cancer stem cells (CSCs) are thought to seed GBM’s inevitable recurrence by evading standard of care treatment, which combines surgical resection, radiotherapy, and chemotherapy, co...

Descripción completa

Detalles Bibliográficos
Autores principales: Silver, Aryeh, Feier, Diana, Ghosh, Tanya, Rahman, Maryam, Huang, Jianping, Sarkisian, Matthew R., Deleyrolle, Loic P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628999/
https://www.ncbi.nlm.nih.gov/pubmed/36338705
http://dx.doi.org/10.3389/fonc.2022.1022716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628999/
https://www.ncbi.nlm.nih.gov/pubmed/36338705
http://dx.doi.org/10.3389/fonc.2022.1022716

Ejemplares similares